🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.Rutgers Cancer Institute RWJBarnabas expert Dr. Coral Omene Coral Omene, MD, PhD presents "Triple Negative Breast Cancer in Black women: the genomic rearrangement landscape and its relationship to obesity and neoadjuvant treatment outcomes" at #AACRdisp24.

Dr. Coral Omene, a medical oncologist in the Breast Oncology Program Rutgers Cancer Institute, spoke about #breastcancer risk for Black women, early detection and how health care disparities may affect treatment with #MosaicNJ. Check out her interview: mosaic.nj.com/community/2024…

Watch Live: Vice President Harris and Michelle Obama rally supporters in Kalamazoo, Michigan x.com/i/broadcasts/1…

Dr. Gerardo Capo, Dr. Coral Omene Coral Omene, MD, PhD, and Dr. Mariam Eskander Mariam Eskander lead an important and very informative discussion about enrollment of underserved populations in #clinicaltrials at the Rutgers Cancer Institute Annual Oncology Clinical Practice and Research Summit.

BTCRC-BRE16-042 has been accepted as a poster presentation at SABCS 2024! This study is led by sponsor-investigator Nancy Chan, MD & co-investigator Coral Omene, MD, PhD. Congratulations to all co-authors and study teams involved in the study! Read more: bigtencrc.org/btcrc-bre16-04…

Congratulations to our excellent Oncology Fellow Dr. Noveihed presenting her poster on a clinical vignette at #SABCS24, Rutgers Cancer Institute

HAPPENING NOW! The results of ph2 IRENE study for pts w mTNBC #tnbc with oncolytc virus Pelareorep Oncolytics Biotech and Retifanlimab Incyte. Ohio State Medical Oncology Nicole Williams MD Rutgers Cancer Institute RWJBarnabas Robert Wood Johnson University Hospital OncoAlert #sabcs24

Congratulations to Rutgers Cancer Institute and George Mason University collaborators on your #SABCS24 poster, validation of HER2 activation response predictive signature (HARPS) as predictive biomarker for HER2+ therapy response in neoadj setting. Coral Omene, MD, PhD Mridula George

Happening Now! P2-08-25 Learn more about ongoing Ph2 study evaluating Tirzepatide for weight loss in HR+/HER2 neg EBC Rutgers Cancer Institute Robert Wood Johnson University Hospital #sabcs24 OncoAlert #bcsm

Annual gathering of the Big Ten CRC #breastcancer research team at #SABCS24. Oana Danciu Peyton Reves Darian Louthan Malinda T West Kari Wisinski Anne Schott, MD Coral Omene, MD, PhD Mark Burkard Marina Sharifi Mridula George

Congratulations to all on the collaborative efforts to successfully complete our IIT, Ph2 trial with Fulvestrant/Pembrolizumab in ER+ MBC👏🏼👏🏼.Rutgers Cancer Institute Big Ten Cancer Research Consortium #SABCS24

Thanks so much to Coral Omene, MD, PhD, of Rutgers RWJMedSchool and Rutgers Cancer Institute, for speaking with us at #SABCS24 about the FITWISE study of tirzepatide for weight loss intervention in early-stage HR+/HER2– breast cancer! See our site for more #bcsm insights! SABCS onclive.com/conference/sab…

HAPPENING NOW PRO with serial ctDNA testing in early breast cancer- CIPHER study Rutgers Cancer Institute OncoAlert RWJBarnabas Coral Omene, MD, PhD Trishala Meghal #bcsm Natera Oncology

Dr. Mariam Eskander & Dr. Coral Omene (Coral Omene, MD, PhD)from Rutgers Cancer Institute & RWJBarnabas highlight barriers to #oncology #clinicaltrials for underserved groups in a recent article with Cancer Network. Read more: cancernetwork.com/view/best-prac…

Dr. Mariam Eskander & Dr. Coral Omene (Coral Omene, MD, PhD) from Rutgers Cancer Institute & RWJBarnabas spoke with Targeted Oncology about barriers to #clinicaltrial access for underserved groups including mistrust, and logistical and systemic hurdles. Watch the interview: hubs.li/Q039MhFv0

ICYMI: Rutgers Cancer Institute & RWJBarnabas experts Dr. Coral Omene Coral Omene, MD, PhD and Dr. Mariam Eskander Mariam Eskander address best practices for boosting the enrollment of underserved populations in cancer clinical trials in Cancer Network CancerNetwork®. cancernetwork.com/view/best-prac…

We are thrilled to reintroduce Across the Consortium, a monthly article showcasing the latest news and events from our member institutions. Click on the link below to read all about what the Big Ten cancer centers are up to! bigtencrc.org/across-the-con…

Proud Rutgers mentor Mariam Eskander taking a photo of superb Rutgers resident Dr. Rachel Sachs, presenting important work while brilliant Rutgers moderator Haejin In looks on! Great job Rachel! #SSO2025 Rutgers Cancer Institute Rutgers RWJMS Surgery Nell Maloney Patel Miral Sadaria Grandhi Coral Omene, MD, PhD Henry Pitt, MD

Clinical researchers at Rutgers Cancer Institute and RWJBarnabas aim to improve breast cancer outcomes through sustainable and effective weight loss in the FITWISE study with a first-of-its-kind clinical trial using tirzepatide. Learn more cinj.org/clinical-resea… Coral Omene, MD, PhD

New & available #OpenAccess | Among Black breast cancer survivors, discrimination was associated with poorer QOL. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Bonnie Qin Jesse Plascak Coral Omene, MD, PhD Dr. Elisa V. Bandera Rutgers Cancer Institute